Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DEVICE MANUFACTURERS COULD ENTER CONTRACTS WITH THIRD PARTIES FOR REVIEWS OF ALL DEVICE TYPES UNDER COATS AMENDMENT TO KASSEBAUM FDA REFORM BILL

This article was originally published in The Gray Sheet

Executive Summary

Manufacturers would have the option to contract directly with accredited third-party organizations for reviews of 510(k)s and premarket approval applications under the amended version of Sen. Nancy Kassebaum's (R-Kan.) FDA reform bill (S 1477) reported out of the Senate Labor and Human Resources Committee March 28.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT005706

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel